William Wang

William Wang Head of Consulting (China)

shanghai

Chinese, English

About William

William is Head of Consulting Research (China). He is based in Shanghai.

Expertise

William is specialised in research spanning competitive intelligence, market positioning and market entry. He also has experience in innovation studies, such as helping clients to map the new brand alternative launch model, profiling research and development innovation process, amongst others. He has served many local and multinational companies, covering industries like packaged food, beauty and personal care, apparel and footwear, and home appliances. William joined Euromonitor in 2012, starting in Consulting in Shanghai as an Associate Consultant, progressing to Consultant and then Senior Consultant. He continues to prove himself to be a valuable project manager, with his strong research sense and excellent communication skills to clients. Since assuming a managerial role in 2016, William has also demonstrated his strong leadership, wealth of experience and a clear, client-centric mindset.

Related to Food and Nutrition

Article

Five Key Snack Trends to Track 2025-2026

4 Aug 25

Amid turbulent tariffs, rising producer costs (eg cocoa commodity price) and dynamic consumer habit shifts, the snacks industry continues to realise the upside to value growth resulting in USD679 billion retail sales in 2024. Euromonitor’s research has identified five key trends critical to industry strategy set to shape snacks in the years ahead.

Carl Quash III

Carl Quash III

Event

Anuga Cologne 2025

Koelnmesse GmbH, Messeplatz 1, 50679, Köln 4 October 2025 11:00 CET

Anuga presents you the future of the food industry on a silver platter. Let yourself be inspired by valuable insights and ideas.

Tom Rees

Tom Rees

Article

The Impact of GLP-1 Drugs on Food and Beverage Demand

19 Jun 25

The use of GLP-1 drugs, which is already exerting a significant impact on the US food and beverage market, is set to rise sharply around the world in 2026. Semaglutide, the active ingredient in drugs like Ozempic, goes off-patent in much of the world that year. This means that millions of people are going to change how they eat and drink in the coming years, with significant impacts on the food and drink industry.

Matthew Barry

Matthew Barry